Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia: A Danish nationwide cohort study

Overweight patients with cancer are frequently reduced in chemotherapy dose due to toxicity concerns, although previous studies have indicated that dose reduction (DR) of overweight patients results in comparable toxicity but may compromise overall survival (OS). Current evidence regarding DR in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristensen, Daniel Tuyet, Nielsen, Lars Børty, Jakobsen, Lasse Hjort Kyneb, Kristensen, Tove‐Christina Choe, Jepsen, Lene Østergaard, Schöllkopf, Claudia, Theilgaard‐Mönch, Kim, El‐Galaly, Tarec Christoffer, Roug, Anne Stidsholt, Severinsen, Marianne Tang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Haematological Malignancy–Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825846/
https://www.ncbi.nlm.nih.gov/pubmed/36083781
http://dx.doi.org/10.1111/bjh.18448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825846/
https://www.ncbi.nlm.nih.gov/pubmed/36083781
http://dx.doi.org/10.1111/bjh.18448

Ejemplares similares